[PHAT] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[PHAT] Phathom Pharmaceuticals, Inc.
Announcement Date
14-Jun-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -84.01%
YoY- -25.40%
Quarter Report
PHAT's Result
PHAT's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 682 0 0 0 0 0 -
PBT -79,570 -55,047 -35,826 -53,721 -98,006 -484 177.29%
Tax -16,738 8,405 -6,788 1,188 -43,582 5 -
NP -79,570 -63,452 -35,826 -53,721 -98,006 -484 177.29%
Tax Rate - - - - - - -
Total Cost 80,252 63,452 35,826 53,721 98,006 484 177.76%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -11,667.16 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -1.39 -1.54 -0.95 -1.58 -3.02 -0.06 87.42%
EPS Diluted -1.39 -1.54 -0.95 -1.58 -3.02 -0.06 87.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.